Interleukin-10 (IL-10) can favour the development of fibrosis by promoting a relative shift towards T helper 2 responses. Three single base pair substitutions in the 5′ flanking region of the IL-10 gene (G/A -1082, C/T -819 and C/A -592) influence the amount of IL-10 secreted in cell cultures: the GCC haplotype is associated with an increased production, while the ACC and the ATA haplotypes are associated with intermediate and decreased production. Accordingly, three phenotypes have been individuated: high producers (GCC +/GCC +), medium producers (GCC +/GCC -) and low producers (GCC -/GCC -). We hypothesised that IL-10 haplotypes and genotypes are differently expressed in patients with systemic sclerosis (SSc) with the limited cutaneous SSc (lcSSc) subset or the diffuse cutaneous SSc (dcSSc) subset. One hundred and sixty-one unrelated Italian patients with SSc and 94 controls have been included. Their DNA was extracted and stored before being analysed by polymerase chain reaction with sequence-specific primers. The GCC haplotype is overrepresented in patients with SSc; subjects with dcSSc were the primary contributors to these results (dcSSc: 52.2% vs controls: 37.2%; χ 2 = 8.519, 2 d.f., corrected P = 0.04). In Scl70-positive patients, the GCC haplotype increased the likelihood of presenting the dcSSc subset [χ 2 = 12.56, P < 0.0005; odds ratio (OR) = 3.89, 95% confidence interval (CI 95) = 1.69-9.08]; these results were confirmed at the phenotypic level (χ 2 = 11.67, 2 d.f., P = 0.003). In Scl70-positve patients, the high-producing phenotype was associated with poor survival, independently from disease subset and gender (hazard ratio = 9.9, CI 95 = 1.6-61.27, P < 0.05). The IL-10 haplotype and genotype associated with high IL-10 production may alter the susceptibility to SSc and/or its expression, increasing the prognostic value of other well-known markers of disease severity.

Proximal interleukin-10 gene polymorphism in italian patients with systemic sclerosis / L. Beretta, F. Cappiello, M. Barili, R. Scorza. - In: TISSUE ANTIGENS. - ISSN 0001-2815. - 69:4(2007 Apr), pp. 305-312.

Proximal interleukin-10 gene polymorphism in italian patients with systemic sclerosis

M. Barili
Penultimo
;
R. Scorza
Ultimo
2007

Abstract

Interleukin-10 (IL-10) can favour the development of fibrosis by promoting a relative shift towards T helper 2 responses. Three single base pair substitutions in the 5′ flanking region of the IL-10 gene (G/A -1082, C/T -819 and C/A -592) influence the amount of IL-10 secreted in cell cultures: the GCC haplotype is associated with an increased production, while the ACC and the ATA haplotypes are associated with intermediate and decreased production. Accordingly, three phenotypes have been individuated: high producers (GCC +/GCC +), medium producers (GCC +/GCC -) and low producers (GCC -/GCC -). We hypothesised that IL-10 haplotypes and genotypes are differently expressed in patients with systemic sclerosis (SSc) with the limited cutaneous SSc (lcSSc) subset or the diffuse cutaneous SSc (dcSSc) subset. One hundred and sixty-one unrelated Italian patients with SSc and 94 controls have been included. Their DNA was extracted and stored before being analysed by polymerase chain reaction with sequence-specific primers. The GCC haplotype is overrepresented in patients with SSc; subjects with dcSSc were the primary contributors to these results (dcSSc: 52.2% vs controls: 37.2%; χ 2 = 8.519, 2 d.f., corrected P = 0.04). In Scl70-positive patients, the GCC haplotype increased the likelihood of presenting the dcSSc subset [χ 2 = 12.56, P < 0.0005; odds ratio (OR) = 3.89, 95% confidence interval (CI 95) = 1.69-9.08]; these results were confirmed at the phenotypic level (χ 2 = 11.67, 2 d.f., P = 0.003). In Scl70-positve patients, the high-producing phenotype was associated with poor survival, independently from disease subset and gender (hazard ratio = 9.9, CI 95 = 1.6-61.27, P < 0.05). The IL-10 haplotype and genotype associated with high IL-10 production may alter the susceptibility to SSc and/or its expression, increasing the prognostic value of other well-known markers of disease severity.
Interleukin-10; Polymorphism; Systemic sclerosis
Settore MED/09 - Medicina Interna
apr-2007
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/43882
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 25
social impact